ReviewThe Indian journal of medical research2026
Evolution of incretin-based therapies: From GLP-1 monotherapy to dual and triple agonists: A new era in metabolic therapy.
Monika Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.